Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alex Davis

Orthopaedic Surgery The Woodlands, TX Medical Doctor

NPI 1629336805 CMS profile 119356

17183 I-45 South Ste 210, The Woodlands, TX 77385

Open in the dashboard

General payments

$64,170

181 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alex Davis of The Woodlands, TX is reported in the CMS Open Payments database as having received $64,170 across 181 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $47,251 58
2024 General $5,665 19
2023 General $1,676 15
2022 General $4,711 47
2021 General $1,412 7
2020 General $185 4
2019 General $3,271 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alex Davis
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Alex Davis were reported at $47,251. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Alex Davis Orthopaedic Surgery median Middle half National median
2019 $3,271 $644 $140–$2,844 $163
2020 $185 $312 $75–$1,860 $114
2021 $1,412 $520 $117–$2,495 $132
2022 $4,711 $598 $128–$2,731 $149
2023 $1,676 $461 $128–$2,264 $160
2024 $5,665 $497 $134–$2,475 $164
2025 $47,251 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Treace Medical Concepts, Inc. $27,150 26 payments
  2. Linvatec Corporation $23,405 25 payments
  3. Arthrex, Inc. $5,205 25 payments
  4. Medinc of Texas $4,084 12 payments
  5. Stryker Corporation $1,514 25 payments
  6. TriMed, Inc. $466 8 payments
  7. Encore Medical, LP $388 6 payments
  8. Wright Medical Technology, Inc. $200 11 payments
  9. Acera Surgical, Inc. $191 1 payment
  10. DePuy Synthes Sales Inc. $154 6 payments
  11. Other $1,412 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $37,150 11 payments
  2. Travel and Lodging $15,577 33 payments
  3. Food and Beverage $6,230 132 payments
  4. Education $5,213 5 payments
Products named General payments · program years 2019–2025
  1. LAPIPLASTY SYSTEM 1 $26,217 17 payments
  2. COLINK 2 $9,750 3 payments
  3. COLINK PLATING SYSTEM $9,500 4 payments
  4. QUANTUM $2,980 11 payments
  5. BIOBRACE 23MM $527 4 payments
  6. IBS $493 2 payments
  7. LAPIPLASTY $340 1 payment
  8. PROSTEP MICA $322 2 payments
  9. INFINITY ADAPTIS $306 3 payments
  10. AUGMENT INJECTABLE $300 8 payments
  11. Other $3,822 97 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

422

Median for Orthopedic Surgery: 203

Drug cost

$2,966

Median for Orthopedic Surgery: $1,433

Branded share of claims

21.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 166 $1,336
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 77 $676
Celecoxib Generic 19 $330
Meloxicam Generic 51 $233
Ondansetron Hcl Generic 63 $172
Acetaminophen-Codeine Acetaminophen With Codeine Brand 12 $120
Oxycodone Hcl Generic 12 $49
Tramadol Hcl Generic 22 $49

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 98 billing codes

Paid by Medicare

$113,895

Of which drugs: $342

Medicare patients

325

Average age 74

Services billed

1,543

217 women, 108 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 72%
Ischemic heart disease 38%
Diabetes 27%
Depression 27%
Osteoporosis 24%
Atrial fibrillation 22%
Chronic kidney disease 22%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 69 316 $238

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

181 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record